HARS1 and Charcot-Marie-Tooth disease: Most of these mutations fall within the HARS catalytic domain and are associated with an autosomal dominant neurological disorder, Charcot-Marie-Tooth disease (CMT-type 2W) (Figure 2B) [38,39,40,41,42].